Skip to main content
Clinical Trials/NCT01637740
NCT01637740
Completed
Not Applicable

Pseudoexfoliation Syndrome in Myopes Defined With Optical Low Coherence Reflectometry

General Hospital Sveti Duh0 sites5,753 target enrollmentAugust 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pseudoexfoliation Syndrome in Cataract Myopic Eyes
Sponsor
General Hospital Sveti Duh
Enrollment
5753
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

A retrospective study of 5753 eyes of cataract surgery patients was conducted at our Clinic. Ocular optical components measured by optical low coherence reflectometry biometer LENSTAR LS 900® of the cataract myopic eyes with pseudoexfoliation syndrome were put in comparison with those of cataract myopic eyes group without pseudoexfoliation syndrome.

Detailed Description

A retrospective study of 5753 eyes of cataract surgery patients was conducted at investigators Clinic in a period of 2.5 years. Pseudoexfoliation syndrome was found in 255 eyes. There were only 26 cataract myopic eyes with pseudoexfoliation syndrome. Refractive eye state was defined by preoperatively calculated emmetropization intraocular lens (IOL) value done by optical low coherence reflectometry biometer LENSTAR LS 900®. Ocular optical components of the cataract myopic eyes with pseudoexfoliation syndrome measured by this biometer were put in comparison with matched cataract myopic eyes group without pseudoexfoliation syndrome that have emmetropization IOL value within the same range as the cataract myopic eyes with pseudoexfoliation syndrome.

Registry
clinicaltrials.gov
Start Date
August 2009
End Date
January 2012
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
General Hospital Sveti Duh
Responsible Party
Principal Investigator
Principal Investigator

Mladen Busic

M.D., PhD

General Hospital Sveti Duh

Eligibility Criteria

Inclusion Criteria

  • cataract surgery patients ≥ 40 years old

Exclusion Criteria

  • cataract surgery patients \< 40 years old

Outcomes

Primary Outcomes

Not specified

Similar Trials